EnWave (CVE:ENW) Trading Down 3%

EnWave Co. (CVE:ENWGet Rating)’s stock price traded down 3% during mid-day trading on Thursday . The company traded as low as C$0.48 and last traded at C$0.48. 32,745 shares traded hands during mid-day trading, a decline of 30% from the average session volume of 46,778 shares. The stock had previously closed at C$0.50.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. Cormark cut their price target on EnWave from C$0.70 to C$0.60 in a research note on Wednesday, August 24th. Raymond James lowered their price objective on EnWave from C$1.10 to C$0.85 and set a “market perform” rating on the stock in a research report on Tuesday, August 30th.

EnWave Price Performance

The firm has a market capitalization of C$53.01 million and a P/E ratio of -17.14. The company has a quick ratio of 1.63, a current ratio of 2.98 and a debt-to-equity ratio of 13.22. The business’s 50-day simple moving average is C$0.60 and its 200 day simple moving average is C$0.70.

EnWave (CVE:ENWGet Rating) last posted its quarterly earnings results on Monday, August 22nd. The company reported C($0.02) earnings per share for the quarter, missing the consensus estimate of C($0.01) by C($0.01). The business had revenue of C$5.55 million for the quarter, compared to analyst estimates of C$8.19 million. Sell-side analysts forecast that EnWave Co. will post -0.01 earnings per share for the current year.

About EnWave

(Get Rating)

EnWave Corporation designs, constructs, markets, licenses, installs, and sells vacuum-microwave machinery for the food, cannabis, and biomaterial dehydration industries in Canada and the United States. It offers radiant energy vacuum (REV) dehydration platforms, such as nutraREV and quantaREV to dehydrate fruits, vegetables, herbs, dairy products, ready-to-eat meals, instant baked goods, cannabis products, nutraceuticals, pharmaceuticals, and meats and seafood.

Featured Stories

Receive News & Ratings for EnWave Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EnWave and related companies with MarketBeat.com's FREE daily email newsletter.